Home
Conditions
Recurrence

Clinical trial condition

Recurrence

Explore clinical trials studying Recurrence. Study availability and eligibility vary by location and protocol.

2,310 public trials 520 recruiting studies

Refine in advanced search Browse all conditions

Recurrence trial results

Recruiting

Study of C6 Ceramide NanoLiposome (CNL) in Patients With Relapsed/Refractory Acute Myeloid Leukemia

NCT04716452

Conditions: Acute Myeloid Leukemia, Refractory, Acute Myeloid Leukemia, in Relapse, Disease Attributes, +11 more
Locations: University of Virginia Cancer Center Charlottesville, Virginia, United States

View Trial Details

Recruiting

Dual-Target GD2/B7-H3 CAR-NK Cells for Pediatric Relapsed or Refractory Neuroblastoma

NCT07502287

Conditions: Disease Attributes, Ganglioneuroblastoma, High-risk Neuroblastoma, +15 more
Locations: Peking University Shenzhen Hospital Shenzhen, Guangdong, China

View Trial Details

Recruiting

Pembrolizumab Plus Ultrasound-Induced Microbubble Cavitation in Head and Neck Cancer

NCT07501650

Conditions: Disease Attributes, Head and Neck Cancer, Head and Neck Neoplasms, +8 more
Locations: Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University Philadelphia, Pennsylvania, United States

View Trial Details

Recruiting

Dutasteride in Patients With Low Grade Non-muscle Invasive Bladder Cancer

NCT07420517

Conditions: Bladder Cancer, Disease Attributes, Female Urogenital Diseases, +13 more
Locations: CHU de Québec - Université Laval Québec, Quebec, Canada

View Trial Details

Recruiting

NexCAR19 (Talikabtagene Autoleucel) in Relapsed/Refractory B-Cell Malignancies (NexCAR19)

NCT07502118

Conditions: Burkitt Lymphoma, Cytokine Release Syndrome, DNA Virus Infections, +29 more
Locations: Ankara Bilkent City Hospital - Hematology Clinic Ankara, Turkey (Türkiye)

Ankara Etlik City Hospital - Hematology Clinic Ankara, Turkey (Türkiye)

Hacettepe University Faculty of Medicine - Department of Internal Medicine, Division of Hematology Ankara, Turkey (Türkiye)

University of Health Sciences Dr. Abdurrahman Yurtaslan Ankara Oncology Training and Research Hospital Ankara, Turkey (Türkiye)

View Trial Details

Recruiting

Iadademstat + SBRT With Atezo in ES-SCLC

NCT07113691

Conditions: Disease Attributes, Extensive Stage Small Cell Lung Cancer (ES-SCLC), Pathologic Processes, +2 more
Locations: Yale University New Haven, Connecticut, United States

View Trial Details

Recruiting

The Safety and Tolerability of LBS-007 in Patients With Relapsed or Resistant Acute Leukaemias

NCT05756322

Conditions: Disease Attributes, Pathologic Processes, Pathological Conditions, Signs and Symptoms, +2 more
Locations: Moffitt Cancer Center Tampa, Florida, United States

Robert H. Lurie Comprehensive Cancer Center of Northwestern University Chicago, Illinois, United States

The University of Kansas Hospital Fairway, Kansas, United States

Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins Baltimore, Maryland, United States

View all 17 locations

View Trial Details

Recruiting

MIMICC Study in Patients With Colorectal Cancer

NCT07494201

Conditions: Anastomotic Leak, Colon Cancer, Colonic Diseases, +19 more
Locations: Unit of Surgical Oncology - Fondazione del Piemonte per l'Oncologia- IRCCS Istituto di Candiolo, Candiolo, Turin 10060 Candiolo, Torino (TO), Italy

View Trial Details

Recruiting

A Phase 1/2 Study of Enzomenib (DSP-5336) in Patients With Acute Leukemia (Horizen-1)

NCT04988555

Conditions: Blood Protein Disorders, Bone Marrow Diseases, Cardiovascular Diseases, +25 more
Locations: Hoag Family Cancer Center Newport Beach, California, United States

Stanford University Palo Alto, California, United States

Colorado Blood Cancer Institute Denver, Colorado, United States

Georgetown Lombardi Comprehensive Cancer Center Washington D.C., District of Columbia, United States

View all 104 locations

View Trial Details

Recruiting

Enhancing CAR-T Cell Therapy Efficacy in B-cell Lymphoma Via Chidamide and PD-1 Inhibitor Combination.

NCT07489989

Conditions: Disease Attributes, Hemic and Lymphatic Diseases, Immune System Diseases, +13 more
Locations: Chinese PLA General Hospital Beijing, Beijing Municipality, China

View Trial Details

Recurrence

Recurrence trial results

Related conditions